Cargando…
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne
OBJECTIVES: Peritoneal carcinomatosis is the most frequent site of metastases in patients with gastric cancer. Current standard treatment is palliative systemic chemotherapy with very poor prognosis. Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) resulted...
Autores principales: | Casella, Francesco, Bencivenga, Maria, Rosati, Riccardo, Fumagalli, Uberto Romario, Marrelli, Daniele, Pacelli, Fabio, Macrì, Antonio, Donini, Annibale, Torroni, Lorena, Pavarana, Michele, De Manzoni, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467896/ https://www.ncbi.nlm.nih.gov/pubmed/36159218 http://dx.doi.org/10.1515/pp-2022-0111 |
Ejemplares similares
-
10 Years of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): A Systematic Review and Meta-Analysis
por: Di Giorgio, Andrea, et al.
Publicado: (2023) -
Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) as an outpatient procedure
por: Graversen, Martin, et al.
Publicado: (2018) -
Radiologist Checklist for Selecting Patients to Undergo PIPAC (Pressurized IntraPeritoneal Aerosol Chemotherapy)
por: Rodolfino, Elena, et al.
Publicado: (2021) -
Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM)
por: Casella, Francesco, et al.
Publicado: (2023) -
Renal and Hepatic Toxicities After Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)
por: Blanco, Ana, et al.
Publicado: (2013)